Pramipexole dihydrochloride
NDC 50742-335, Pramipexole dihydrochloride, tablet, extended release, from Ingenus Pharmaceuticals, LLC.
- Product NDC
- 50742-335
- Status
- Listed
- Labeler
- Ingenus Pharmaceuticals, LLC
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA213444
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/50742-335 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PRAMIPEXOLE DIHYDROCHLORIDE3 mg/1
Pharmacologic classes
Dopamine Agonists [MoA]; Nonergot Dopamine Agonist [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 50742-335-30 | 50742033530 | 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (50742-335-30) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/1d2b1d2c-ae22-424a-bad7-ce24a817b042NADAC price for package 50742033530
GET /v1/drugs/nadac/50742033530
Use it
Look up 50742-335 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/50742-335 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 50742-335. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.